Scarica il manuale per operatori - GenitoriPiù

prendiamoci più cura della loro vita
Riferimenti bibliografici
– Badovinac RL, Werler MM, Williams PL, Kelsey KT, Hayes C. Folic acid-containing supplement consumption
during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol
Teratol 2007, 79: 8-15.
– Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LC, Gindler J, Hong
S, Correa A, for the China-US Collaborative Project for Neural Tube Defect Prevention. Prevention of
neural-tube defects with folic acid in China. N Engl J Med 1999, 341: 1485-90.
– Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other
than neural tube defects. Am J Med Genet 2004, 125: 12-21.
– Charles DH, Ness AR, Campbell D, Smith GD, Whitley E, Hall MH. Folic acid supplements in pregnancy
and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane
review. Paediatr Perinat epidemiol 2005, 19: 112-24.
– Czeizel AE, Puho E. Maternal use of nutritional supplements during the first month of pregnancy and
decreased risk of Down’s syndrome: case-control study. Nutrition 2005, 21: 698-704.
– Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional
multivitamin supplementation. Final report. Arch Gynecol Obstet 1994, 255: 131-9.
– Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional
vitamin supplementation. N Engl J Med 1992, 327: 1832-5.
– Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet 2006, 367:
1352-61.
– Finnell RH, Shaw GM, Lammer EJ, Volcik KA. Does prenatal screening for 5,10-methylenetetrahydrofolate
reductase (MTHFR) mutations in high-risk neural tube defect pregnancies make
sense? Genet Test 2002, 6: 47-52.
– Goh YI, Bollano E, Einarson TR, Koren G. Prenatal Multivitamin Supplementation and Rates of Pediatric
Cancers: A Meta-Analysis. Clin Pharmacol Ther 2007, 81: 685-91.
– Goh YI, Bollano E, Einarson TR, Koren G. Prenatal Multivitamin Supplementation and Rates of Congenital
Anomalies: A Meta-Analysis. J Obstet Gynaecol Can 2006, 28: 680-9.
– Kallen B. Use of folic acid supplementation and risk for dizygotic twinning. Early Hum Dev 2004, 80:
143-51.
– MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the MRC Vitamin
Study. Lancet 1991, 338: 131-7.
– Muggli EE, Halliday JL. Folic acid and risk of twinning: a systematic review of the recent literature,
July 1994 to July 2006. MJA 2007, 186: 243-8.
– Van der Pal-de Bruin KM, de Walle HE, Jeeninga W, de Rover C, Cornel MC, de Jong-van den Berg
LT, Schouten J, Brand R, Buitendijk SE. The Dutch ‘Folic Acid Campaign’ – have the goals been
achieved? Paediatr Perinat Epidemiol 2000, 14: 111-7.
– Wald NJ, Oakley GP, Hubner RA, Houlston RD, Muir KR. Should folic acid fortification be mandatory?
BMJ 2007, 334: 1252-3.
– Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001, 358: 2069-73.
Link utili: www.cdc.gov; www.marchofdimes.com; www.motherisk.org; www.pensiamociprima.net;
www.folictrial.org; www.iss.it/cnmr; www.gasbi.it; www.spinabifidaveneto.it.
68